INVVY logo

INVVY Indivior PLC

Other OTC · Drug Manufacturers - Specialty & Generic · Healthcare

$21.85
+0.00 (+0.00%)

Indivior PLC, encompassing its various subsidiaries, is a pharmaceutical firm dedicated to the research, production, and global commercialization of prescription medications. These therapies primarily utilize buprenorphine to treat opioid dependence and associated medical conditions. The company's development pipeline is actively exploring novel treatments for opioid use disorder (OUD) and schizop…

Market Cap: $3.01Bwww.indivior.com

Price

No data yet.

Social Signal Score

49
5d
—
30d
50
2 mentions
—
60d
51
4 mentions
—
90d
44
6 mentions
—
news: 6

Analyst Ratings

1 analyst
Holdconsensus
Strong Buy 0Buy 0Hold 1Sell 0Strong Sell 0
Avg price target$50+128.9%
Low $50Median $50High $50
Current Consensus

Revenue

$356.00M+59.64%
$207.00M$257.33M$307.67M$358.00M
Dec 2021Sep 2026

Company Profile

CEO
Mark Crossley
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,000
Beta
-0.06
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
2.84
www.indivior.com